Skip to content

Bioavailability of Xanthones From Mangosteen

Bioavailability and Anti-inflammatory Activities of Mangostins: a Pilot Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01425047
Enrollment
10
Registered
2011-08-29
Start date
2010-11-30
Completion date
2011-02-28
Last updated
2011-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Keywords

mangosteen, xanthones, dietary supplement, botanical supplement, bioavailability, Determine bioavailability of mangosteen xanthones in adults

Brief summary

Mangosteen is a tropical tree. The peel of mangosteen fruit is used in traditional medicine. The purpose of this study was to determine the bioavailability of the xanthones from mangosteen juice in adult human subjects.

Detailed description

Garcinia mangostana L. (mangosteen) is a tropical tree native to Southeast Asia. The pericarp of mangosteen fruit is used in traditional medicine to treat inflammation, infections, wounds, and diarrhea. The proposed health-promoting effects have been attributed to a family of polyphenols referred to as xanthones. Since its introduction into the United States, juices and products containing mangosteen fruit have become a top-selling botanical dietary supplement. This commercial success largely has been the result of aggressive marketing of health claims based on in vitro observations and anecdotal reports. The purpose of this study was to determine the bioavailability of xanthones from mangosteen juice in adult human subjects. After an overnight fast of at least 10h, male and female subjects were admitted to the Ohio State University Clinical Research Center. Volunteers ingested 2 ounces of 100% mangosteen juice as part of a western-style breakfast. Pericarp particles accounted for 1% of the mass and 99% of total xanthone content in the juice. This dose provided 130 ± 2 mg total xanthones. Blood was collected prior to breakfast and 1,2,3,4,6,8 and 24h. Subjects were fed a mangosteen-free lunch and released from the unit after the 8h collection, refraining from mangosteen containing products until final collection of blood at 24h. Urine was collected for the 24 test period.

Interventions

None listed

Sponsors

Ohio State University
CollaboratorOTHER
Mark Failla
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* 5 female * 5 male * body mass index \</= 30 * normal renal function * non-smoking

Exclusion criteria

* smokers * acute or chronic diseases * history of gastrointestinal diseases * \>/= 10% weight loss * dietary or herbal supplement within 6 months of study * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Xanthones in urine0-24 hoursUrine was collected prior to ingesting mangosteen juice with breakfast and then from consumpotion of juice until 24h.

Secondary

MeasureTime frameDescription
Xanthones in sera0-24 hoursBlood was collected prior to breakfast, and 1, 2, 3, 4, 6, 8 and 24 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026